Scientific & Regulatory Advisory Services

Market pressures continue to change the focus and structure of the drug development industry with a heavy emphasis on accelerating preclinical development to move the most efficacious therapies into the clinic. The preclinical drug development journey is rarely straight and often requires course corrections and pivots. Our Scientific and Regulatory Advisors can help your program.

Ask us How

Charles River consultants work tirelessly to help you navigate the drug development process as the route of a new drug, biologic, or device from concept to commercialization is rarely linear or easy.